4.7 Article

The Rett Syndrome Protein MeCP2 Regulates Synaptic Scaling

Journal

JOURNAL OF NEUROSCIENCE
Volume 32, Issue 3, Pages 989-994

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.0175-11.2012

Keywords

-

Categories

Funding

  1. NIH [MH068578]
  2. Rett Syndrome Research Foundation/International Rett Syndrome Foundation
  3. Chinese Academy of Sciences, China

Ask authors/readers for more resources

Synaptic scaling is a form of homeostatic synaptic plasticity characterized by cell-wide changes in synaptic strength in response to changes in overall levels of neuronal activity. Here we report that bicuculline-induced increase in neuronal activity leads to a decrease in mEPSC amplitude and a decrease in expression of the AMPA receptor subunit GluR2 in rat hippocampal cultures. Bicuculline treatment also leads to an increase in the levels of the transcriptional repressor MeCP2, which binds to the GluR2 promoter along with the corepressors HDAC1 and mSin3A. Downregulation of MeCP2 by shRNA expression or genetic deletion blocks the bicuculline-induced decrease in GluR2 expression and mEPSC amplitude. These observations indicate that MeCP2 mediates activity-dependent synaptic scaling, and suggest that the pathophysiology of Rett syndrome, which is caused by mutations in MeCP2, may involve defects in activity-dependent regulation of synaptic currents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available